Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm

The term coronary artery spasm (CAS) refers to a sudden, intense vasoconstriction of an epicardial coronary artery that causes vessel occlusion or near occlusion. Although CAS may be involved in other coronary syndromes, it represents the usual cause of variant angina. The variant form of angina was first described in 1959 by Prinzmetal et al,1 who used this term to indicate that angina attacks, unlike the most common form of effort angina, occurred at rest and were associated with ST-segment elevation, rather than ST-segment depression, on the ECG (Figure 1). Because myocardial ischemia occurred in the absence of any change in myocardial oxygen demand, the authors hypothesized that it was caused by an increased tonus of vessels at the level of coronary stenoses.1 Figure 1. (Top) ST-segment elevation in anterior leads, with reciprocal mild ST-segment depression in inferior leads and V6, during an angina attack in a patient with variant angina. (Bottom) Normalization of the ECG after spontaneous resolution of chest pain. Some years later, in fact, coronary angiography, performed during spontaneous angina attacks, demonstrated that CAS is the usual cause of variant angina.2–4 Coronary angiography also showed that CAS could occur at the site of a stenosis (either minor or severe) or in angiographically normal coronary arteries,5 usually at a localized segment of an epicardial artery (focal spasm) (Figure 2).6 However, sometimes CAS involves 2 or more segments of the same (multifocal spasm) or of different (multivessel spasm) epicardial coronary arteries, or may also involve diffusely one or multiple coronary branches.7 Figure 2. Occlusive spasm of the left circumflex coronary artery and near occlusive spasm of the left anterior descending coronary artery (arrows) during coronary angiography (left, top), associated with dramatic ST-segment elevation at monitoring ECG leads (left, bottom). Complete resolution of spasm (right, …

[1]  A. Hata,et al.  Angiotensin Converting Enzyme as a Genetic Risk Factor for Coronary Artery Spasm , 2013 .

[2]  H. Shimokawa,et al.  Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.

[3]  Jaime Gonzalez,et al.  The role of oxidative stress in the pathophysiology of hypertension , 2011, Hypertension Research.

[4]  髙木 祐介 Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest : multicenter registry study of the Japanese coronary spasm association , 2011 .

[5]  K. Kaikita,et al.  Background of guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) , 2011 .

[6]  H. Shimokawa,et al.  Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[7]  T. Akasaka,et al.  Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[8]  H. Soejima Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2008) , 2010 .

[9]  J. Mercé,et al.  Kounis syndrome: report of 5 cases. , 2010, Journal of investigational allergology & clinical immunology.

[10]  A. John Camm,et al.  The Esc Textbook of Cardiovascular Medicine , 2009 .

[11]  D. Jacobs,et al.  Oxidative Stress and Insulin Resistance , 2009, Diabetes Care.

[12]  G. Niccoli,et al.  Coronary artery vasospasm causing ventricular fibrillation - an external loop recording. , 2009, Resuscitation.

[13]  A. Maseri,et al.  Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[14]  F. Crea,et al.  Chronic Ischaemic Heart Disease , 2009 .

[15]  H. Shimokawa,et al.  Myocardial ischemia: current concepts and future perspectives. , 2008, Journal of cardiology.

[16]  M. Horie,et al.  Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. , 2008, Journal of the American College of Cardiology.

[17]  K. Hirano Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. , 2007, Journal of pharmacological sciences.

[18]  F. Crea,et al.  Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. , 2007, International journal of cardiology.

[19]  E. Romagnoli,et al.  Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications. , 2007, International journal of cardiology.

[20]  Juan P Casas,et al.  Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. , 2006, American journal of epidemiology.

[21]  F. Levy,et al.  5-hydroxytryptamine receptors in the human cardiovascular system. , 2006, Pharmacology & therapeutics.

[22]  F. Tondato,et al.  Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs. , 2006, Cardiovascular revascularization medicine : including molecular interventions.

[23]  K. Park,et al.  Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. , 2006, American heart journal.

[24]  J. Taguchi,et al.  Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[25]  F. Crea,et al.  Coronary artery spasm induced by capecitabine. , 2006, Journal of cardiovascular medicine.

[26]  A. E. Menyar Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. , 2006 .

[27]  Ayman A El Menyar Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. , 2006, Journal of postgraduate medicine.

[28]  H. Kasanuki,et al.  [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris]. , 2005, Journal of cardiology.

[29]  M. Fujita,et al.  Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm , 2005, Heart and Vessels.

[30]  V. Jayam,et al.  Coronary vasospasm and myocardial infarction induced by oral sumatriptan. , 2004, Clinical neuropharmacology.

[31]  U. Arora,et al.  5-fluorouracil-induced coronary vasospasm. , 2004, Cancer control : journal of the Moffitt Cancer Center.

[32]  E. Romagnoli,et al.  Increased platelet sodium–hydrogen exchanger activity in patients with variant angina , 2003, Heart.

[33]  C. Napoli,et al.  Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[34]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[35]  M. Wheeler,et al.  Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. , 2002, The Journal of clinical investigation.

[36]  H. Tomita,et al.  Enhanced Activity of Variant Phospholipase C-&dgr;1 Protein (R257H) Detected in Patients With Coronary Artery Spasm , 2002, Circulation.

[37]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[38]  K. Kugiyama,et al.  Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina. , 2001, Japanese circulation journal.

[39]  A. Takeshita,et al.  Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. , 2000, Circulation.

[40]  R. Mongiardo,et al.  Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. , 2000, Circulation.

[41]  H. Takaoka,et al.  Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. , 1999, The American journal of cardiology.

[42]  F. Crea,et al.  Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina. , 1999, Cardiologia.

[43]  D. Gutterman Adventitia-dependent influences on vascular function. , 1999, American journal of physiology. Heart and circulatory physiology.

[44]  A. Takeshita,et al.  Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.

[45]  A. Maseri,et al.  Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.

[46]  T. Paavonen,et al.  Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. , 1999, Circulation.

[47]  T. Hirai,et al.  Consumption of vitamin E in coronary circulation in patients with variant angina. , 1999, Cardiovascular research.

[48]  K. Kugiyama,et al.  Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.

[49]  K. Kanazawa,et al.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.

[50]  A. Takeshita,et al.  Platelet activating factor causes hyperconstriction at the inflammatory coronary lesions in pigs in vivo , 1997, Coronary artery disease.

[51]  Y. Yazaki,et al.  Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. , 1997, Journal of cardiovascular pharmacology.

[52]  F. Crea,et al.  Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. , 1996, Journal of the American College of Cardiology.

[53]  A. Takeshita,et al.  Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo , 1996 .

[54]  H. Inoue,et al.  Vitamin E deficiency in variant angina. , 1996, Circulation.

[55]  M. Hori,et al.  Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. , 1996, The American journal of cardiology.

[56]  A. Takeshita,et al.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.

[57]  A. Takeshita,et al.  Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo. , 1996, Circulation.

[58]  H. Ishizaka,et al.  Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. , 1996, Journal of the American College of Cardiology.

[59]  A. Hata,et al.  Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. , 1995, The Journal of clinical investigation.

[60]  J. Morrow,et al.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.

[61]  F. Takatsu,et al.  Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.

[62]  A. Castellanos,et al.  Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[63]  A. Takeshita,et al.  Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. , 1992, The Journal of clinical investigation.

[64]  F. Crea,et al.  Clinical and Angiographic Characteristics of 10 Patients with Prinzmetal ' s Variant Angina Pectoris Cholesterol Coronary arteriography Age CAD ( mg / dl ) ST at initial evaluation Follow-up Patient ( years ) Sex risk factors Entry Outset , 2005 .

[65]  F. Crea,et al.  Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. , 1991, Journal of the American College of Cardiology.

[66]  A. Maseri,et al.  Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. , 1991, The New England journal of medicine.

[67]  M. Yanagisawa,et al.  Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.

[68]  D. Mazur,et al.  The hyperventilation challenge test. Another means of identifying coronary vasospasm in patients with angina-like chest pain. , 1991, Chest.

[69]  K. Kugiyama,et al.  Magnesium deficiency detected by intravenous loading test in variant angina pectoris. , 1990, The American journal of cardiology.

[70]  F. Crea,et al.  Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. , 1989, Journal of the American College of Cardiology.

[71]  A. Maseri,et al.  Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. , 1989, The American journal of cardiology.

[72]  A. Takeshita,et al.  Increased fibrinopeptide A during anginal attacks in patients with variant angina. , 1989, Journal of the American College of Cardiology.

[73]  H. Shimokawa,et al.  Endothelium‐Derived Relaxing Factor and Coronary Vasospasm , 1989, Circulation.

[74]  M. Nakamura,et al.  Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. , 1988, International journal of cardiology.

[75]  M. Nakamura,et al.  Attenuation of Endothelium‐Related Relaxation and Enhanced Responsiveness of Vascular Smooth Muscle to Histamine in Spastic Coronary Arterial Segments From Miniature Pigs , 1987, Circulation research.

[76]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.

[77]  F. Crea,et al.  Provocation of coronary spasm by dopamine in patients with active variant angina pectoris. , 1986, Circulation.

[78]  R. Virmani,et al.  Increased adventitial mast cells in a patient with coronary spasm. , 1985, The New England journal of medicine.

[79]  K. Tanaka,et al.  Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. , 1985, American heart journal.

[80]  D. Waters,et al.  Circadian variation in variant angina. , 1984, The American journal of cardiology.

[81]  R. de Caterina,et al.  A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm. , 1984, Circulation.

[82]  F. Crea,et al.  alpha-Adrenergic receptors and coronary spasm: an elusive link. , 1984, Circulation.

[83]  D. Robertson,et al.  Arterial and coronary sinus catecholamines in the course of spontaneous coronary artery spasm. , 1983, American heart journal.

[84]  M. Winniford,et al.  Alpha–adrenergic Blockade for Variant Angina: A Long–term, Double–blind, Randomized Trial , 1983, Circulation.

[85]  A. Mussini,et al.  Failure of Thromboxane A2 Blockade to Prevent Attacks of Vasospastic Angina , 1982, Circulation.

[86]  B. McManus,et al.  Sudden death in Prinzmetal's angina with coronary spasm documented by angiography. Analysis of three necropsy patients. , 1982, The American journal of cardiology.

[87]  M. Bertrand,et al.  Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.

[88]  A. Maseri,et al.  ROLE OF CORONARY ARTERIAL SPASM IN SUDDEN CORONARY ISCHEMIC DEATH , 1982, Annals of the New York Academy of Sciences.

[89]  F. Crea,et al.  Effects of Intravenous Prostacyclin in Variant Angina , 1982, Circulation.

[90]  W. Vaughn,et al.  Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.

[91]  M. Inoue,et al.  Elevation of Thromboxane B2 Levels in Patients with Classic and Variant Angina Pectoris , 1981, Circulation.

[92]  D. Harrison,et al.  Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. , 1981, American heart journal.

[93]  G. FitzGerald,et al.  Thromboxane A2 in Vasotonic Angina Pectoris , 1981 .

[94]  G. FitzGerald,et al.  Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. , 1981, The New England journal of medicine.

[95]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[96]  R. Miller,et al.  Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.

[97]  A. Maseri,et al.  Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.

[98]  R. Macalpin,et al.  Contribution of Dynamic Vascular Wall Thickening to Luminal Narrowing During Coronary Arterial Constriction , 1980, Circulation.

[99]  G. Specchia,et al.  Coronary Arterial Spasm as a Cause of Exercise‐Induced ST‐Segment Elevation in Patients with Variant Angina , 1979, Circulation.

[100]  W. C. Sheldon,et al.  Ergonovine maleate provocative test for coronary arterial spasm. , 1978, The American journal of cardiology.

[101]  G. Thiene,et al.  Prinzmetal's variant angina: clinical, angiographic and pathologic correlations in two typical cases. , 1976, European journal of cardiology.

[102]  J. S. Siegel The Variant Form of Angina Pectoris , 1976, Southern medical journal.

[103]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. , 1975, American journal of epidemiology.

[104]  C. Marchesi,et al.  Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in Man , 1975 .

[105]  L. Zir,et al.  Variant angina associated with angiographically demonstrated coronary artery spasm and REM sleep. , 1973, The American journal of the medical sciences.

[106]  D. E. Potts,et al.  Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. , 1973, The New England journal of medicine.

[107]  T. Cheng,et al.  Variant Angina of Prinzmetal with Normal Coronary Arteriograms: A Variant of the Variant , 1973, Circulation.

[108]  G. Hammond,et al.  Alcohol-induced Prinzmetal variant angina. , 1973, The American journal of cardiology.

[109]  G. Gensini,et al.  Arteriographic Demonstration of Coronary Artery Spasm and Its Release After the Use of a Vasodilator in a Case of Angina Pectoris and in the Experimental Animal , 1962, Angiology.

[110]  M. Prinzmetal,et al.  Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.